1. Home
  2. STE vs ILMN Comparison

STE vs ILMN Comparison

Compare STE & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STERIS plc (Ireland)

STE

STERIS plc (Ireland)

HOLD

Current Price

$201.71

Market Cap

20.9B

Sector

Health Care

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$162.26

Market Cap

24.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STE
ILMN
Founded
1985
1998
Country
United States
United States
Employees
3700
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9B
24.6B
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
STE
ILMN
Price
$201.71
$162.26
Analyst Decision
Buy
Hold
Analyst Count
5
17
Target Price
$275.20
$124.24
AVG Volume (30 Days)
704.6K
1.7M
Earning Date
05-11-2026
04-30-2026
Dividend Yield
1.19%
N/A
EPS Growth
27.90
170.87
EPS
7.93
0.87
Revenue
$5,935,900,000.00
$4,343,000,000.00
Revenue This Year
$9.88
$6.47
Revenue Next Year
$6.32
$5.58
P/E Ratio
$25.48
$185.16
Revenue Growth
8.73
N/A
52 Week Low
$195.14
$88.00
52 Week High
$269.44
$177.22

Technical Indicators

Market Signals
Indicator
STE
ILMN
Relative Strength Index (RSI) 38.37 56.82
Support Level $195.14 $155.55
Resistance Level $227.10 $177.22
Average True Range (ATR) 4.47 6.68
MACD -0.82 -1.01
Stochastic Oscillator 24.73 29.44

Price Performance

Historical Comparison
STE
ILMN

About STE STERIS plc (Ireland)

Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: